← All trials
NCT04545736
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 8, 2021
- Primary completion
- Aug 31, 2026
- Completion date
- Aug 31, 2026
- First posted
- Sep 11, 2020
- Last posted
- Jan 5, 2021
- Enrollment
- 44
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Eye Institute (NEI)Lead sponsor
- National Eye Institute (NEI)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.